Rare presentation of Fabry disease as ‘burnt-out’ hypertrophic cardiomyopathy

Fabry disease with early-onset ventricular dilation

(2020) Jia Tang et al.   MEDICINE

Relative Wall Thickness and the Risk for Ventricular Tachyarrhythmias in Patients With Left Ventricular Dysfunction

(2016) Yitschak Biton et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Fabry disease and the heart

(2015) Nora Seydelmann et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Patterns of Disease Progression in Hypertrophic Cardiomyopathy

(2012) Iacopo Olivotto et al.   Circulation-Heart Failure

Enzyme replacement therapy for Fabry disease: a systematic review and meta-analysis

(2012) Taciane Alegra et al.   GENETICS AND MOLECULAR BIOLOGY

Cardiac magnetic resonance imaging illustrating Anderson–Fabry disease progression

(2010) M Imbriaco et al.   BRITISH JOURNAL OF RADIOLOGY

Long-Term Effects of Enzyme Replacement Therapy on Fabry Cardiomyopathy

(2009) Frank Weidemann et al.   CIRCULATION

Dilated phase of hypertrophic cardiomyopathy caused by Fabry disease with atrial flutter and ventricular tachycardia

(2008) Koji Fukuzawa et al.   Journal of Cardiology

Effects of enzyme replacement therapy on the cardiomyopathy of Anderson Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa

(2007) D A Hughes et al.   HEART